We are live on ! Find out more
SRSA

S.R. Schill & Associates Portfolio holdings

AUM $166M
1-Year Est. Return 17.84%
This Fund
S&P 500
This Quarter Est. Return
+5.36%
1 Year Est. Return
+17.84%
3 Year Est. Return
+36.72%
5 Year Est. Return
+35.26%
10 Year Est. Return
+161.3%
AUM
$136M
AUM Growth
+$10.3M
Cap. Flow
+$4.05M
Cap. Flow %
2.99%
Top 10 Hldgs %
86.02%
Holding
32
New
3
Increased
14
Reduced
6
Closed
6

Sector Composition

Rank Sector Weight
1 Real Estate 3.04%
2 Technology 2.66%
3 Industrials 0.72%
4 Materials 0.38%
5 Consumer Staples 0.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MVIS icon
26
Microvision
MVIS
$78.9M
$74.9K 0.06%
4,382
GOOGL icon
27
Alphabet (Google) Class A
GOOGL
$4.33T
-1,851
Closed -$286K
META icon
28
Meta Platforms (Facebook)
META
$1.51T
-367
Closed -$212K
NFLX icon
29
Netflix
NFLX
$309B
-2,890
Closed -$270K
UNP icon
30
Union Pacific
UNP
$174B
-953
Closed -$225K
V icon
31
Visa
V
$677B
-585
Closed -$205K
XBI icon
32
State Street SPDR S&P Biotech ETF
XBI
$10.3B
-41,595
Closed -$3.37M

Similar funds

S.R. Schill & Associates's Q2 2025 Portfolio in Review

As of Q2 2025, S.R. Schill & Associates held 32 positions worth $136M, up 8.2% from $125M the previous quarter. Its ten largest holdings account for 86% of the portfolio.

S.R. Schill & Associates's Q2 2025 filing shows 3 new, 14 increased, 6 reduced and 6 closed positions. Its largest new stake was Vanguard Long-Term Corporate Bond ETF: 17,387 shares worth $1.32M. The largest sale was State Street SPDR S&P Biotech ETF, an estimated $3.37M.

By sector, the portfolio is most concentrated in Real Estate at 3% of assets, down from 3.4% a quarter earlier, followed by Technology and Industrials.

  • S.R. Schill & Associates's largest Q2 2025 buy was Vanguard Long-Term Corporate Bond ETF: 17,387 shares worth $1.32M.
  • S.R. Schill & Associates added most to Vanguard Russell 2000 ETF in Q2 2025, an estimated $3.92M increase.
  • S.R. Schill & Associates's biggest Q2 2025 reduction was Vanguard Long-Term Treasury ETF, cutting an estimated $947K.
  • S.R. Schill & Associates fully exited State Street SPDR S&P Biotech ETF in Q2 2025, selling an estimated $3.37M.
  • S.R. Schill & Associates's ten largest holdings make up 86% of its $136M portfolio in Q2 2025.
  • S.R. Schill & Associates opened 3 new positions and closed 6 in Q2 2025.
  • S.R. Schill & Associates's portfolio value rose 8.2% quarter-over-quarter to $136M.

Based on S.R. Schill & Associates's 13F filing for Q2 2025, filed 2 Jul 2025.